GNMSF Financials
Genmab A/S - Financial statements & key metrics
Stock Price
$290.00
Market Cap
$17.86B
P/E Ratio
18.9
EPS
$15.37
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$24.54B
Gross Profit
$22.51B
Operating Income
$8.25B
Net Income
$6.35B
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$81.68B
Total Liabilities
$44.58B
Shareholders Equity
$37.10B
Cash & Equivalents
$10.88B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$7.83B
CapEx
$244.13M
Free Cash Flow
$7.58B
Profitability Metrics
Gross Margin
93.6%
Operating Margin
0.2%
Net Margin
0.3%
ROE
0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is GNMSF revenue?
GNMSF's most recent quarterly revenue was $24.54B. Annual revenue can be calculated by summing the four most recent quarters.
Is GNMSF profitable?
GNMSF reported a profit of $6.35B in the most recent quarter. The net profit margin is 0.3%.
What is GNMSF market cap?
GNMSF has a market capitalization of $17.86B, making it a large-cap stock.
Does GNMSF have debt?
View GNMSF's balance sheet for debt information.
What is GNMSF cash flow?
GNMSF's most recent quarterly free cash flow was $7.58B.